| 000 | 01902 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513230839.0 | ||
| 264 | 0 | _c20010322 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0363-6119 | ||
| 024 | 7 |
_a10.1152/ajpregu.2001.280.3.R713 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPang, C Y | |
| 245 | 0 | 0 |
_aAmplification effect and mechanism of action of ET-1 in U-46619-induced vasoconstriction in pig skin. _h[electronic resource] |
| 260 |
_bAmerican journal of physiology. Regulatory, integrative and comparative physiology _cMar 2001 |
||
| 300 |
_aR713-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid _xpharmacology |
| 650 | 0 | 4 | _aAlkaloids |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBenzophenanthridines |
| 650 | 0 | 4 |
_aCalcium _xpharmacology |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEndothelin-1 _xadministration & dosage |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 |
_aPhenanthridines _xpharmacology |
| 650 | 0 | 4 |
_aPhorbol 12,13-Dibutyrate _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSkin _xblood supply |
| 650 | 0 | 4 | _aSwine |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 700 | 1 | _aXu, H | |
| 700 | 1 | _aHuang, N | |
| 700 | 1 | _aForrest, C R | |
| 700 | 1 | _aPerréault, T M | |
| 700 | 1 | _aNeligan, P C | |
| 773 | 0 |
_tAmerican journal of physiology. Regulatory, integrative and comparative physiology _gvol. 280 _gno. 3 _gp. R713-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpregu.2001.280.3.R713 _zAvailable from publisher's website |
| 999 |
_c11110547 _d11110547 |
||